REQUEST FOR EXTENSION OF PROTECTION
SERIAL NUMBER: 79284023 FILING DATE: 03/10/2020
The table below presents the data as entered.
Input Field
|
Entered
|
| MARK SECTION |
| IMAGE |
\\TICRS\EXPORT18\IMAGEOUT18\792\840\79284023\xml1\APP0002.JPG |
| COLLECTIVE, CERTIFICATE OR GUARANTEE MARK |
NO |
| MARK IN STANDARD CHARACTERS |
NO |
| MARK IN COLOR |
YES |
| COLOR CLAIMED FOR MARK |
Coral pink and green |
| THREE DIMENSIONAL MARK |
NO |
| SOUND MARK |
NO |
| THE WORDS CONTAINED IN THE MARK HAVE NO MEANING (AND THEREFORE CANNOT BE TRANSLATED) |
YES |
| TM IMAGE: COLOR |
YES |
| IMAGE FILE NAME |
\\TICRS\EXPORT18\IMAGEOUT18\792\840\79284023\xml1\APP0002.JPG |
| TYPE (IMAGE TYPE) |
JPG |
| TEXTUAL ELEMENTS OF MARK |
Vijoice |
| HOLDER DETAILS |
| CLIENT IDENTIFIER |
499832 |
| NOTIFICATION LANGUAGE |
FRENCH |
| NAME |
NOVARTIS AG |
| ADDRESS |
CH-4002 Basel |
| COUNTRY |
Switzerland |
| ENTITLEMENT ESTABLISHMENT |
Switzerland |
| LEGAL NATURE |
Aktiengesellschaft |
| LEGAL NATURE: PLACE INCORPORATED |
Suisse |
| LIMITATION DETAILS |
| DESIGNATED CONTRACTING PARTY CODE |
United States of America |
| GOODS AND SERVICES LIMITED TO |
05 |
| GOODS AND SERVICES LIMITED TO |
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals;
dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the
central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of
diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in
hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and
treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and
treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical
preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for
use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical
preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma. |
| BASIC GOODS AND SERVICES |
| VERSION OF NICE CLASSIFICATION USED |
11-2020 |
| NICE CLASSIFICATION |
05 |
| GOODS AND SERVICES |
Pharmaceutical preparations. |
| PARIS PRIORITY DETAILS |
| PARIS PRIORITY CODE: |
Switzerland |
| PARIS PRIORITY APPLICATION NUMBER |
744101 |
| PARIS PRIORITY APPLICATION DATE |
03/06/2020 |
| BASE REGISTRATION DETAILS |
| BASE REGISTRATION NUMBER |
744101 |
| BASE REGISTRATION DATE |
03/06/2020 |
| CORRESPONDENCE DETAILS |
| CLIENT IDENTIFIER |
649965 |
| NAME |
Novartis Pharma AG, |
| |
Trademark Department |
| ADDRESS |
Postfach |
| |
CH-4002 Basel |
| COUNTRY |
Switzerland |
| INTENT TO USE GROUP |
| CONTRACTING PARTY CODE |
United States of America |
| DESIGNATIONS |
| DESIGNATIONS UNDER THE PROTOCOL |
United States of America |
| INTERNATIONAL REGISTRATION DETAILS |
| INTERNATIONAL REGISTRATION NUMBER |
1527051 |
| INTERNATIONAL REGISTRATION DATE OF MARK |
03/10/2020 |
| INTERNATIONAL REGISTRATION EXPIRY DATE |
03/10/2030 |
| EFFECTIVE DATE OF MODIFICATION |
03/10/2020 |
| NOTIFICATION DATE |
04/23/2020 |
| DATE OF RECORDAL IN INTERNATIONAL REGISTER |
04/10/2020 |
| IB DOCUMENT ID |
1339257801 |
| OFFICE OF ORIGIN CODE |
Switzerland |
| OFFICE REFERENCE |
79284023 |
| TRANSACTION TYPE VALUES |
Initial Designation |
| ORIGINAL LANGUAGE |
FRENCH |
| INSTRUMENT UNDER WHICH CONTRACTING PARTY IS DESIGNATED |
Protocol |
| DURATION OF MARK (YEARS) |
10 |
| VIENNA CLASSIFICATION VERSION USED |
7 |
| VIENNA CLASS |
2601 |
| VIENNA CLASS |
2705 |
| VIENNA CLASS |
2901 |
